DURHAM, N.C., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that Kenneth I. Moch, President and CEO of Chimerix, will present at the 16(th) Annual BIO CEO & Investor Conference on Monday, February 10, 2014 at 4:30pm EST at the Waldorf Astoria in New York City.
A live audio webcast of the presentation will be available on the Investor Relations section of Chimerix's website at
http://ir.chimerix.com/events.cfm, where it will be archived for 90 days.
